The Proteoglycan Biglycan Modulates Platelet Adhesion and Thrombus Formation in a GPVI-Dependent Manner
Open Access
- 10 November 2021
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (22) , 12168
Abstract
Background: Vascular injury induces the exposure of subendothelial extracellular matrix (ECM) important to serve as substrate for platelets to adhere to the injured vessel wall to avoid massive blood loss. Different ECM proteins are known to initiate platelet adhesion and activation. In atherosclerotic mice, the small, leucine-rich proteoglycan biglycan is important for the regulation of thrombin activity via heparin cofactor II. However, nothing is known about the role of biglycan for hemostasis and thrombosis under nonatherosclerotic conditions. Methods: The role of biglycan for platelet adhesion and thrombus formation was investigated using a recombinant protein and biglycan knockout mice. Results: The present study identified biglycan as important ECM protein for the adhesion and activation of platelets, and the formation of three-dimensional thrombi under flow conditions. Platelet adhesion to immobilized biglycan induces the reorganization of the platelet cytoskeleton. Mechanistically, biglycan binds and activates the major collagen receptor glycoprotein (GP)VI, because reduced platelet adhesion to recombinant biglycan was observed when GPVI was blocked and enhanced tyrosine phosphorylation in a GPVI-dependent manner was observed when platelets were stimulated with biglycan. In vivo, the deficiency of biglycan resulted in reduced platelet adhesion to the injured carotid artery and prolonged bleeding times. Conclusions: Loss of biglycan in the vessel wall of mice but not in platelets led to reduced platelet adhesion at the injured carotid artery and prolonged bleeding times, suggesting a crucial role for biglycan as ECM protein that binds and activates platelets via GPVI upon vessel injury.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (Collaborative Research Center 1116; International Research Training Group 1902)
This publication has 46 references indexed in Scilit:
- Biological interplay between proteoglycans and their innate immune receptors in inflammationThe FEBS Journal, 2013
- The Proteoglycan Biglycan Enhances Antigen-Specific T Cell Activation Potentially via MyD88 and TRIF Pathways and Triggers Autoimmune PerimyocarditisThe Journal of Immunology, 2011
- Small Leucine-Rich Proteoglycans in Kidney DiseaseJournal of the American Society of Nephrology, 2011
- The proteoglycan biglycan regulates expression of the B cell chemoattractant CXCL13 and aggravates murine lupus nephritisJournal of Clinical Investigation, 2010
- Platelet hyperreactivity and a prothrombotic phenotype in mice with a gain‐of‐function mutation in phospholipase Cγ2Journal of Thrombosis and Haemostasis, 2010
- Biglycan, a Danger Signal That Activates the NLRP3 Inflammasome via Toll-like and P2X ReceptorsJournal of Biological Chemistry, 2009
- Biglycan Deficiency Causes Spontaneous Aortic Dissection and Rupture in MiceCirculation, 2007
- The matrix component biglycan is proinflammatory and signals through Toll-like receptors 4 and 2 in macrophagesJournal of Clinical Investigation, 2005
- Biglycan and decorin induce morphological and cytoskeletal changes involving signalling by the small GTPases RhoA and Rac1 resulting in lung fibroblast migrationJournal of Cell Science, 2003
- Transcriptional Regulation of the Human Biglycan GeneJournal of Biological Chemistry, 1996